PET imaging of tumor hypoxia using ¹⁸F-labeled pimonidazole

By Busk Morten   Jakobsen Steen   Horsman Michael R.   Mortensen Lise S.   Iversen Ane B.   Overgaard Jens   Nordsmark Marianne   Ji Xiaosheng   Lee David Y.   Raleigh James R.  

Acta Oncologica, Vol. 52, Iss. 7, 2013-10 ,pp. : 1300-1307

Informa Healthcare

Access to resources Recommend Favorite

Hypoxia and Perfusion Measurements in Human Tumors—Initial Experience with Pimonidazole and IUdR

By Begg Adrian C.   Janssen Hilde   Sprong Debbie   Hofland Ingrid   Blommestijn Gerard   Raleigh James A.   Varia Mahesh   Balm Alfons   van Velthuyzen Loes   Delaere Pierre   Sciot Raf   Haustermans Karin M. G.  

Acta Oncologica, Vol. 40, Iss. 8, 2001-12 ,pp. : 924-928

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of changes in the tumor microenvironment after sorafenib therapy by sequential histology and 18F-fluoromisonidazole hypoxia imaging in renal cell carcinoma

By                  

International Journal of Oncology, Vol. 41, Iss. 5, 2012-01 ,pp. : 1593-1600

Spandidos Publications

Access to resources Recommend Favorite

Effects of hypoxia on tumor metabolism

By Kim Jung-whan   Gao Ping   Dang Chi  

Cancer and Metastasis Reviews, Vol. 26, Iss. 2, 2007-06 ,pp. : 291-298

Springer Publishing Company

Access to resources Recommend Favorite

CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma

By                      

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 465-472

Spandidos Publications

Access to resources Recommend Favorite